{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:53:29Z","timestamp":1771030409371,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Natural Science Foundation of Chongqing municipality","award":["cstc2021jcyj-msxmX0387"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0387"]}]},{"name":"Medical Scientific Research Project of Chongqing Municipal Health Commission","award":["2022WSJK027"],"award-info":[{"award-number":["2022WSJK027"]}]},{"name":"the 2021 SKY Imaging Research Fund of the Chinese International Medical Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00330-022-08581-1","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T10:06:50Z","timestamp":1649412410000},"page":"4898-4908","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy"],"prefix":"10.1007","volume":"32","author":[{"given":"Xiaoxia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0239-6988","authenticated-orcid":false,"given":"Jiuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"8581_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"8581_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1470-2045(17)30914-2","volume":"19","author":"MGM Derks","year":"2018","unstructured":"Derks MGM, van de Velde CJH (2018) Neoadjuvant chemotherapy in breast cancer: more than just downsizing. Lancet Oncol 19:2\u20133","journal-title":"Lancet Oncol"},{"key":"8581_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.6004\/jnccn.2018.0012","volume":"16","author":"WJ Gradishar","year":"2018","unstructured":"Gradishar WJ, Anderson BO, Balassanian R et al (2018) Breast cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 16:310\u2013320","journal-title":"J Natl Compr Cancer Netw"},{"key":"8581_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jchf.2018.09.001","volume":"7","author":"A Banke","year":"2019","unstructured":"Banke A, Fosbol EL, Ewertz M et al (2019) Long-term risk of heart failure in breast cancer patients after adjuvant chemotherapy with or without trastuzumab. JACC Heart Fail 7:217\u2013224","journal-title":"JACC Heart Fail"},{"key":"8581_CR5","first-page":"40","volume":"107","author":"E Matos","year":"2016","unstructured":"Matos E, Jug B, Blagus R, Zakotnik B (2016) A prospective cohort study on cardiotoxicity of adjuvant trastuzumab therapy in breast cancer patients. Arq Bras Cardiol 107:40\u201347","journal-title":"Arq Bras Cardiol"},{"key":"8581_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.taap.2015.08.022","volume":"289","author":"JD Schumacher","year":"2015","unstructured":"Schumacher JD, Guo GL (2015) Mechanistic review of drug-induced steatohepatitis. Toxicol Appl Pharmacol 289:40\u201347","journal-title":"Toxicol Appl Pharmacol"},{"key":"8581_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/17425255.2017.1246534","volume":"13","author":"A Dash","year":"2017","unstructured":"Dash A, Figler RA, Sanyal AJ, Wamhoff BR (2017) Drug-induced steatohepatitis. Expert Opin Drug Metab Toxicol 13:193\u2013204","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"8581_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.aohep.2019.11.012","volume":"19","author":"L Meunier","year":"2020","unstructured":"Meunier L, Larrey D (2020) Chemotherapy-associated steatohepatitis. Ann Hepatol 19:597\u2013601","journal-title":"Ann Hepatol"},{"key":"8581_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2017.02.031","volume":"67","author":"L Vigano","year":"2017","unstructured":"Vigano L, De Rosa G, Toso C et al (2017) Reversibility of chemotherapy-related liver injury. J Hepatol 67:84\u201391","journal-title":"J Hepatol"},{"key":"8581_CR10","first-page":"2355","volume":"24","author":"F Inci","year":"2019","unstructured":"Inci F, Karatas F (2019) Paclitaxel-induced hepatic steatosis in patients with breast cancer. J BUON 24:2355\u20132360","journal-title":"J BUON"},{"issue":"1264-1281","key":"8581_CR11","doi-asserted-by":"publisher","first-page":"e1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R (2019) Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156(1264-1281):e1264","journal-title":"Gastroenterology"},{"key":"8581_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejrad.2018.08.008","volume":"107","author":"SCN Hui","year":"2018","unstructured":"Hui SCN, So HK, Chan DFY et al (2018) Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease. Eur J Radiol 107:7\u201313","journal-title":"Eur J Radiol"},{"key":"8581_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1148\/radiol.10100659","volume":"258","author":"T Yokoo","year":"2011","unstructured":"Yokoo T, Shiehmorteza M, Hamilton G et al (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258:749\u2013759","journal-title":"Radiology"},{"key":"8581_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1148\/radiol.10100708","volume":"258","author":"S Meisamy","year":"2011","unstructured":"Meisamy S, Hines CD, Hamilton G et al (2011) Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 258:767\u2013775","journal-title":"Radiology"},{"key":"8581_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1200\/JCO.2009.23.8527","volume":"28","author":"N Chaosuwannakit","year":"2010","unstructured":"Chaosuwannakit N, D\u2019Agostino R Jr, Hamilton CA et al (2010) Aortic stiffness increases upon receipt of anthracycline chemotherapy. J Clin Oncol 28:166\u2013172","journal-title":"J Clin Oncol"},{"key":"8581_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1634\/theoncologist.2015-0352","volume":"21","author":"GJ Koelwyn","year":"2016","unstructured":"Koelwyn GJ, Lewis NC, Ellard SL et al (2016) Ventricular-arterial coupling in breast cancer patients after treatment with anthracycline-containing adjuvant chemotherapy. Oncologist 21:141\u2013149","journal-title":"Oncologist"},{"key":"8581_CR17","first-page":"822","volume":"85","author":"W Zhang","year":"2019","unstructured":"Zhang W, Xie K, Fu S et al (2019) Comparison of the incidence of perioperative cardiovascular risk events among patients with and without a history of neoadjuvant chemotherapy. Minerva Anestesiol 85:822\u2013829","journal-title":"Minerva Anestesiol"},{"key":"8581_CR18","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.jacc.2017.09.1095","volume":"70","author":"HM Chang","year":"2017","unstructured":"Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ETH (2017) Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: Part 2. J Am Coll Cardiol 70:2552\u20132565","journal-title":"J Am Coll Cardiol"},{"key":"8581_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/RCT.0000000000001063","volume":"44","author":"X Zeng","year":"2020","unstructured":"Zeng X, Wang X, Chen H et al (2020) Evaluating the image quality of monoenergetic images from dual-energy computed tomography with low-concentration and low-flow-rate contrast media for the arterials supply to the nipple-areola complex in breast cancer compared with conventional computed tomography angiography. J Comput Assist Tomogr 44:921\u2013927","journal-title":"J Comput Assist Tomogr"},{"key":"8581_CR20","doi-asserted-by":"publisher","first-page":"e009829","DOI":"10.1161\/CIRCIMAGING.119.009829","volume":"13","author":"E Eisenberg","year":"2020","unstructured":"Eisenberg E, McElhinney PA, Commandeur F et al (2020) Deep learning-based quantification of epicardial adipose tissue volume and attenuation predicts major adverse cardiovascular events in asymptomatic subjects. Circ Cardiovasc Imaging 13:e009829","journal-title":"Circ Cardiovasc Imaging"},{"key":"8581_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40620-018-0491-5","volume":"31","author":"R Russo","year":"2018","unstructured":"Russo R, Di Iorio B, Di Lullo L, Russo D (2018) Epicardial adipose tissue: new parameter for cardiovascular risk assessment in high risk populations. J Nephrol 31:847\u2013853","journal-title":"J Nephrol"},{"key":"8581_CR22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/apt.15660","volume":"51","author":"JB Henson","year":"2020","unstructured":"Henson JB, Simon TG, Kaplan A, Osganian S, Masia R, Corey KE (2020) Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 51:728\u2013736","journal-title":"Aliment Pharmacol Ther"},{"key":"8581_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","volume":"126","author":"J Cai","year":"2020","unstructured":"Cai J, Zhang XJ, Ji YX, Zhang P, She ZG, Li H (2020) Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases. Circ Res 126:679\u2013704","journal-title":"Circ Res"},{"key":"8581_CR24","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","volume":"20","author":"S Ballestri","year":"2014","unstructured":"Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G (2014) Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol 20:1724\u20131745","journal-title":"World J Gastroenterol"},{"key":"8581_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M et al (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11\u201320","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8581_CR26","doi-asserted-by":"crossref","unstructured":"Tana C, Ballestri S, Ricci F et al (2019) Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications. Int J Environ Res Public Health 16","DOI":"10.3390\/ijerph16173104"},{"key":"8581_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1148\/radiol.2017161228","volume":"284","author":"JP Kuhn","year":"2017","unstructured":"Kuhn JP, Meffert P, Heske C et al (2017) Prevalence of fatty liver disease and hepatic iron overload in a northeastern German population by using quantitative MR imaging. Radiology 284:706\u2013716","journal-title":"Radiology"},{"key":"8581_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1148\/radiol.12112520","volume":"265","author":"JP Kuhn","year":"2012","unstructured":"Kuhn JP, Hernando D, Munoz del Rio A et al (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 265:133\u2013142","journal-title":"Radiology"},{"key":"8581_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clinimag.2021.01.034","volume":"76","author":"EY Kwon","year":"2021","unstructured":"Kwon EY, Kim YR, Kang DM, Yoon KH, Lee YH (2021) Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography. Clin Imaging 76:53\u201359","journal-title":"Clin Imaging"},{"key":"8581_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/RCT.0000000000000113","volume":"38","author":"S Gaubeta","year":"2014","unstructured":"Gaubeta S, Klinghammer L, Jahn D, Schuhback A, Achenbach S, Marwan M (2014) Epicardial fat and coronary artery calcification in patients on long-term hemodialysis. J Comput Assist Tomogr 38:768\u2013772","journal-title":"J Comput Assist Tomogr"},{"key":"8581_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jcct.2015.07.011","volume":"10","author":"MM Hell","year":"2016","unstructured":"Hell MM, Achenbach S, Schuhbaeck A, Klinghammer L, May MS, Marwan M (2016) CT-based analysis of pericoronary adipose tissue density: relation to cardiovascular risk factors and epicardial adipose tissue volume. J Cardiovasc Comput Tomogr 10:52\u201360","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"8581_CR32","doi-asserted-by":"publisher","first-page":"108732","DOI":"10.1016\/j.ejrad.2019.108732","volume":"121","author":"M Marwan","year":"2019","unstructured":"Marwan M, Koenig S, Schreiber K et al (2019) Quantification of epicardial adipose tissue by cardiac CT: influence of acquisition parameters and contrast enhancement. Eur J Radiol 121:108732","journal-title":"Eur J Radiol"},{"key":"8581_CR33","doi-asserted-by":"publisher","first-page":"720690","DOI":"10.3389\/fcvm.2021.720690","volume":"8","author":"A Elsanhoury","year":"2021","unstructured":"Elsanhoury A, Nelki V, Kelle S, Van Linthout S, Tschope C (2021) Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction-a specific HFpEF phenotype. Front Cardiovasc Med 8:720690","journal-title":"Front Cardiovasc Med"},{"key":"8581_CR34","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/jmri.24842","volume":"42","author":"NS Artz","year":"2015","unstructured":"Artz NS, Haufe WM, Hooker CA et al (2015) Reproducibility of MR-based liver fat quantification across field strength: same-day comparison between 1.5T and 3T in obese subjects. J Magn Reson Imaging 42:811\u2013817","journal-title":"J Magn Reson Imaging"},{"key":"8581_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1148\/radiol.2017161786","volume":"284","author":"SD Serai","year":"2017","unstructured":"Serai SD, Dillman JR, Trout AT (2017) Proton density fat fraction measurements at 1.5- and 3-T hepatic MR imaging: same-day agreement among readers and across two imager manufacturers. Radiology 284:244\u2013254","journal-title":"Radiology"},{"key":"8581_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1148\/radiol.12120896","volume":"267","author":"A Tang","year":"2013","unstructured":"Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422\u2013431","journal-title":"Radiology"},{"key":"8581_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jhep.2018.09.024","volume":"70","author":"S Jayakumar","year":"2019","unstructured":"Jayakumar S, Middleton MS, Lawitz EJ et al (2019) Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: analysis of data from a phase II trial of selonsertib. J Hepatol 70:133\u2013141","journal-title":"J Hepatol"},{"key":"8581_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1472-8206.2008.00608.x","volume":"22","author":"G Labbe","year":"2008","unstructured":"Labbe G, Pessayre D, Fromenty B (2008) Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies. Fundam Clin Pharmacol 22:335\u2013353","journal-title":"Fundam Clin Pharmacol"},{"key":"8581_CR39","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/ehjci\/jev024","volume":"16","author":"P Lancellotti","year":"2015","unstructured":"Lancellotti P, Anker SD, Donal E et al (2015) EACVI\/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI\/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology. Eur Heart J Cardiovasc Imaging 16:466\u2013470","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"8581_CR40","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/cvr\/cvz062","volume":"115","author":"R Madonna","year":"2019","unstructured":"Madonna R, Massaro M, Scoditti E, Pescetelli I, De Caterina R (2019) The epicardial adipose tissue and the coronary arteries: dangerous liaisons. Cardiovasc Res 115:1013\u20131025","journal-title":"Cardiovasc Res"},{"key":"8581_CR41","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","volume":"71","author":"M Packer","year":"2018","unstructured":"Packer M (2018) Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol 71:2360\u20132372","journal-title":"J Am Coll Cardiol"},{"key":"8581_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12933-019-0917-y","volume":"18","author":"RH Christensen","year":"2019","unstructured":"Christensen RH, von Scholten BJ, Hansen CS et al (2019) Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes. Cardiovasc Diabetol 18:114","journal-title":"Cardiovasc Diabetol"},{"key":"8581_CR43","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G (2017) Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66:1138\u20131153","journal-title":"Gut"},{"key":"8581_CR44","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/liv.14116","volume":"39","author":"EH van den Berg","year":"2019","unstructured":"van den Berg EH, Wolters AAB, Dullaart RPF et al (2019) Prescription of statins in suspected non-alcoholic fatty liver disease and high cardiovascular risk, a population-based study. Liver Int 39:1343\u20131354","journal-title":"Liver Int"},{"key":"8581_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12957-020-01907-7","volume":"18","author":"LY Xia","year":"2020","unstructured":"Xia LY, Hu QL, Zhang J, Xu WY, Li XS (2020) Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases. World J Surg Oncol 18:129","journal-title":"World J Surg Oncol"},{"key":"8581_CR46","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1148\/radiol.13121360","volume":"267","author":"IS Idilman","year":"2013","unstructured":"Idilman IS, Aniktar H, Idilman R et al (2013) Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 267:767\u2013775","journal-title":"Radiology"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08581-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-08581-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08581-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:07:24Z","timestamp":1655816844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-08581-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["8581"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-08581-1","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Jiuquan Zhang, from the Department of Radiology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, People\u2019s Republic of China (zhangjq_radiol@foxmail.com).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 Retrospective\u2022 Observational\u2022 Performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}